GPR150
gene geneOn this page
Also known as PGR11
Summary
GPR150 (G protein-coupled receptor 150, HGNC:23628) is a protein-coding gene on chromosome 5q15, encoding Probable G-protein coupled receptor 150 (Q8NGU9). Orphan receptor.
This gene encodes an orphan member of the class A rhodopsin-like family of G-protein-coupled receptors (GPCRs). Within the rhodopsin-like family, this gene is a member of the vasopressin-like subfamily that also includes vasopressin and oxytocin receptors. The silencing of this gene, due to promoter methylation, is associated with ovarian cancer progression. All GPCRs have a transmembrane domain that includes seven transmembrane alpha-helices. A general feature of GPCR signaling is the agonist-induced conformational change in the receptor, leading to activation of the heterotrimeric G protein. The activated G protein then binds to and activates numerous downstream effector proteins, which generate second messengers that mediate a broad range of cellular and physiological processes.
Source: NCBI Gene 285601 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 79 total
- Druggable target: yes
- MANE Select transcript:
NM_199243
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23628 |
| Approved symbol | GPR150 |
| Name | G protein-coupled receptor 150 |
| Location | 5q15 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | PGR11 |
| Ensembl gene | ENSG00000178015 |
| Ensembl biotype | protein_coding |
| Entrez | 285601 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000380007
RefSeq mRNA: 1 — MANE Select: NM_199243
NM_199243
CCDS: CCDS4074
Canonical transcript exons
ENST00000380007 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001483357 | 95620087 | 95622142 |
Expression profiles
Bgee: expression breadth ubiquitous, 101 present calls, max score 72.30.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2821 / max 11.9813, expressed in 127 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 57624 | 0.1457 | 76 |
| 57623 | 0.1365 | 70 |
Top tissues by expression
121 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| body of pancreas | UBERON:0001150 | 72.30 | gold quality |
| stromal cell of endometrium | CL:0002255 | 70.08 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 67.22 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 67.16 | gold quality |
| prefrontal cortex | UBERON:0000451 | 66.03 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 65.42 | gold quality |
| pancreas | UBERON:0001264 | 64.93 | gold quality |
| frontal cortex | UBERON:0001870 | 64.38 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 62.87 | gold quality |
| right frontal lobe | UBERON:0002810 | 61.84 | gold quality |
| cerebral cortex | UBERON:0000956 | 61.52 | gold quality |
| primary visual cortex | UBERON:0002436 | 60.03 | gold quality |
| body of stomach | UBERON:0001161 | 58.36 | gold quality |
| fundus of stomach | UBERON:0001160 | 55.63 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 55.35 | gold quality |
| stomach | UBERON:0000945 | 53.99 | gold quality |
| temporal lobe | UBERON:0001871 | 53.17 | gold quality |
| amygdala | UBERON:0001876 | 52.94 | gold quality |
| tibial nerve | UBERON:0001323 | 52.34 | gold quality |
| brain | UBERON:0000955 | 52.03 | gold quality |
| granulocyte | CL:0000094 | 51.95 | gold quality |
| left coronary artery | UBERON:0001626 | 51.14 | gold quality |
| adipose tissue | UBERON:0001013 | 50.91 | gold quality |
| islet of Langerhans | UBERON:0000006 | 50.89 | gold quality |
| lymph node | UBERON:0000029 | 50.62 | gold quality |
| placenta | UBERON:0001987 | 50.09 | gold quality |
| hypothalamus | UBERON:0001898 | 50.05 | gold quality |
| nucleus accumbens | UBERON:0001882 | 49.89 | gold quality |
| popliteal artery | UBERON:0002250 | 49.53 | gold quality |
| tibial artery | UBERON:0007610 | 49.51 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.13 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| drosophila_melanogaster | CrzR | FBGN0036278 |
| caenorhabditis_elegans | WBGENE00013642 |
Paralogs (16): NPFFR2 (ENSG00000056291), GNRHR (ENSG00000109163), CCKBR (ENSG00000110148), HCRTR1 (ENSG00000121764), AVPR2 (ENSG00000126895), GALR3 (ENSG00000128310), HCRTR2 (ENSG00000137252), NPFFR1 (ENSG00000148734), CCKAR (ENSG00000163394), AVPR1A (ENSG00000166148), GALR1 (ENSG00000166573), GPR22 (ENSG00000172209), OXTR (ENSG00000180914), FFAR4 (ENSG00000186188), QRFPR (ENSG00000186867), AVPR1B (ENSG00000198049)
Protein
Protein identifiers
Probable G-protein coupled receptor 150 — Q8NGU9 (reviewed: Q8NGU9)
All UniProt accessions (1): Q8NGU9
UniProt curated annotations — full annotation on UniProt →
Function. Orphan receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_954713* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF00001
UniProt features (21 total): topological domain 8, transmembrane region 7, compositionally biased region 3, region of interest 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NGU9-F1 | 71.04 | 0.34 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-418555 | G alpha (s) signalling events |
MSigDB gene sets: 45 (showing top):
BENPORATH_ES_WITH_H3K27ME3, NFKB_Q6, GOBP_CELLULAR_RESPONSE_TO_HORMONE_STIMULUS, GOBP_RESPONSE_TO_HORMONE, RYTTCCTG_ETS2_B, HOXA4_Q2, YNGTTNNNATT_UNKNOWN, chr5q15, TGGAAA_NFAT_Q4_01, AP1FJ_Q2, ETS_Q4, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3, MEISSNER_NPC_HCP_WITH_H3K4ME2
GO Biological Process (3): G protein-coupled receptor signaling pathway (GO:0007186), cellular response to hormone stimulus (GO:0032870), signal transduction (GO:0007165)
GO Molecular Function (1): G protein-coupled receptor activity (GO:0004930)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| GPCR downstream signalling | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| response to hormone | 1 |
| cellular response to chemical stimulus | 1 |
| cellular response to endogenous stimulus | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| transmembrane signaling receptor activity | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
702 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GPR150 | GPR162 | Q16538 | 571 |
| GPR150 | OXT | P01178 | 569 |
| GPR150 | GNRH2 | O43555 | 548 |
| GPR150 | GPR176 | Q14439 | 516 |
| GPR150 | GPR88 | Q9GZN0 | 513 |
| GPR150 | GPR63 | Q9BZJ6 | 501 |
| GPR150 | GPR26 | Q8NDV2 | 492 |
| GPR150 | GPR82 | Q96P67 | 491 |
| GPR150 | GPR52 | Q9Y2T5 | 486 |
| GPR150 | GPR83 | Q9NYM4 | 485 |
| GPR150 | GPR61 | Q9BZJ8 | 474 |
| GPR150 | GPR139 | Q6DWJ6 | 468 |
| GPR150 | GPR148 | Q8TDV2 | 445 |
| GPR150 | GPR101 | Q96P66 | 444 |
| GPR150 | GPR135 | Q8IZ08 | 437 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GPR150 | PIK3CA | psi-mi:“MI:0914”(association) | 0.350 |
| C10orf90 | GPR150 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (9): INTS2 (Affinity Capture-MS), FANCL (Affinity Capture-MS), KLHL15 (Affinity Capture-MS), INTS1 (Affinity Capture-MS), PDXDC1 (Affinity Capture-MS), GPR150 (Affinity Capture-MS), PPTC7 (Affinity Capture-MS), PIK3CA (Affinity Capture-MS), ABHD17B (Affinity Capture-MS)
ESM2 similar proteins: A0A0U1RQ45, A0A0U1RQS6, A0A286YF58, A0A2R8YCJ5, A0A7I2V3R4, A2VDX9, A5D7M7, A5PJP1, A6NGB7, A6NKF7, A6NLJ0, A8MVW0, B2RU40, C9JH25, C9JTQ0, D4A9R4, P03971, P03972, P0DPE3, P27106, P27539, P79295, Q0VD38, Q14761, Q1HCM0, Q29RK8, Q29RM6, Q2M3V2, Q3SWY4, Q3TYP4, Q5BLP8, Q5T442, Q64697, Q674R7, Q6PEY1, Q6QNY0, Q6ZS72, Q80XF7, Q8BQU6, Q8C581
Diamond homologs: Q8BL07, Q8NGU9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
79 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 73 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
197 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:95621161:A:G | donor_gain | 0.9800 |
| 5:95621234:G:GA | donor_gain | 0.9800 |
| 5:95621236:T:TA | donor_gain | 0.9800 |
| 5:95621233:T:TA | donor_gain | 0.9700 |
| 5:95621251:G:GT | donor_gain | 0.9600 |
| 5:95621237:C:CA | donor_gain | 0.9300 |
| 5:95621342:AGGC:A | acceptor_gain | 0.8700 |
| 5:95621342:AGGCG:A | acceptor_gain | 0.8700 |
| 5:95621343:GGCG:G | acceptor_gain | 0.8700 |
| 5:95621343:GGCGG:G | acceptor_gain | 0.8700 |
| 5:95621184:G:GG | donor_gain | 0.8600 |
| 5:95621263:G:GT | donor_gain | 0.8500 |
| 5:95621192:GC:G | donor_gain | 0.8200 |
| 5:95621343:GGC:G | acceptor_gain | 0.8200 |
| 5:95621259:G:GT | donor_gain | 0.8000 |
| 5:95620966:GTC:G | donor_gain | 0.7900 |
| 5:95620967:TCT:T | donor_gain | 0.7900 |
| 5:95621338:TTCCA:T | acceptor_loss | 0.7900 |
| 5:95621339:TCCAG:T | acceptor_loss | 0.7900 |
| 5:95621340:CCAGG:C | acceptor_loss | 0.7900 |
| 5:95621341:CAGGC:C | acceptor_loss | 0.7900 |
| 5:95621342:A:AG | acceptor_gain | 0.7900 |
| 5:95621342:A:G | acceptor_loss | 0.7900 |
| 5:95621343:G:GG | acceptor_gain | 0.7900 |
| 5:95621343:G:GT | acceptor_loss | 0.7900 |
| 5:95621181:GCT:G | donor_gain | 0.7800 |
| 5:95621260:G:GT | donor_gain | 0.7800 |
| 5:95621183:T:TG | donor_gain | 0.7600 |
| 5:95621186:T:A | donor_gain | 0.7600 |
| 5:95621191:GGC:G | donor_gain | 0.7600 |
AlphaMissense
2684 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 5:95621164:A:C | S297R | 0.978 |
| 5:95621166:C:A | S297R | 0.978 |
| 5:95621166:C:G | S297R | 0.978 |
| 5:95620936:T:C | F221L | 0.957 |
| 5:95620938:C:A | F221L | 0.957 |
| 5:95620938:C:G | F221L | 0.957 |
| 5:95620937:T:G | F221C | 0.955 |
| 5:95620780:T:A | W169R | 0.953 |
| 5:95620780:T:C | W169R | 0.953 |
| 5:95621575:T:C | F434L | 0.951 |
| 5:95621577:C:A | F434L | 0.951 |
| 5:95621577:C:G | F434L | 0.951 |
| 5:95621152:A:C | S293R | 0.945 |
| 5:95621154:C:A | S293R | 0.945 |
| 5:95621154:C:G | S293R | 0.945 |
| 5:95620956:G:C | W227C | 0.931 |
| 5:95620956:G:T | W227C | 0.931 |
| 5:95620996:T:C | F241L | 0.931 |
| 5:95620998:C:A | F241L | 0.931 |
| 5:95620998:C:G | F241L | 0.931 |
| 5:95620553:A:T | D93V | 0.929 |
| 5:95620777:G:C | G168R | 0.921 |
| 5:95620455:C:A | N60K | 0.920 |
| 5:95620455:C:G | N60K | 0.920 |
| 5:95621338:T:C | F355L | 0.915 |
| 5:95621340:C:A | F355L | 0.915 |
| 5:95621340:C:G | F355L | 0.915 |
| 5:95620553:A:C | D93A | 0.907 |
| 5:95621327:T:A | V351D | 0.903 |
| 5:95620554:C:A | D93E | 0.896 |
dbSNP variants (sampled 300 via entrez): RS1000311297 (5:95619114 A>G), RS1000646336 (5:95620152 C>A), RS1000709356 (5:95618828 A>G,T), RS1001536102 (5:95619534 A>G), RS1001881986 (5:95619230 C>T), RS1002285896 (5:95620770 C>T), RS1002349881 (5:95622630 T>C), RS1003555427 (5:95622040 C>G), RS10038242 (5:95620079 A>G), RS1004246811 (5:95621909 G>A), RS1004341725 (5:95621525 G>A), RS1004446754 (5:95618120 A>G), RS1004497127 (5:95618414 A>G), RS1008721505 (5:95619913 G>C), RS1009210183 (5:95622365 C>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4523898 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: gpcr — Class A Orphans with no pharmacology
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression, decreases methylation | 2 |
| fluorene-9-bisphenol | increases expression | 1 |
| terbufos | increases methylation | 1 |
| arsenite | increases methylation | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Fonofos | increases methylation | 1 |
| Parathion | increases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Aflatoxin B1 | decreases expression | 1 |
ChEMBL screening assays
2 unique, capped per target: 2 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4883419 | Binding | PRESTO-Tango GPCRome screening (GPR150) | Data for DCP probe UCSF924 |
Cellosaurus cell lines
2 cell lines: 1 spontaneously immortalized cell line, 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_KX40 | PathHunter CHO-K1 GPR150 beta-arrestin | Spontaneously immortalized cell line | Female |
| CVCL_KZ52 | PathHunter HEK 293 GPR150 beta-arrestin | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.